MedPath

A Clinical Study of efficacy of Nisha-Amalaki churna in on insulin resistance in overweight subjects

Phase 2
Conditions
Health Condition 1: E669- Obesity, unspecified
Registration Number
CTRI/2023/05/052259
Lead Sponsor
Shivani Vinayak Shete
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients who are fulfilling above mentioned diagnostic criteria

2. Patients who are willing for treatment

3. Patients irrespective of their sex, religion and socioeconomic status.

4. Patients between age group 18-60

5. BMI 23 TO 35

Exclusion Criteria

1. Patients with chronic alcoholism

2. Patients with infectious disorder

3. Patients with multiple drug therapy/steroids

4. Pregnant or lactating women

5. Critically ill patients

6. Patients having clinical condition which may interact with either insulin levels or drug action

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the effect of Nisha-Amalaki churna on HOMA-IR in overweight subjects <br/ ><br>Timepoint: 45 days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1) To evaluate the effect of Nisha- Amalaki churna on symptoms of sthaulya. <br/ ><br>2) To see the effect of Nisha- Amalaki churna on hematological parameter (fasting <br/ ><br>plasma insulin level, ESR, BSL fasting and post prandial)Timepoint: 45 days
© Copyright 2025. All Rights Reserved by MedPath